T cell exhaustion during persistent viral infections

Virology

Volumn 479-480, Issue , 2015, Pages 180-193

  Kahan, Shannon M ^a   Wherry, E John ^b   Zajac, Allan J ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytokines; Immunity; Inhibitory receptors; Persistent infections; T cell exhaustion

Indexed keywords

ANIMAL; CHRONIC DISEASE; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; T LYMPHOCYTE; VIROLOGY; VIRUS INFECTION;

ANIMALS; CHRONIC DISEASE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 84930618819     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.12.033     Document Type: Review

References (223)

1. Abrams D., Lévy Y., Losso M.H., Babiker A., Collins G., Cooper D.A., Darbyshire J., Emery S., Fox L., Gordin F., Lane H.C., Lundgren J.D., Mitsuyasu R., Neaton J.D., Phillips A., Routy J.P., Tambussi G., Wentworth D., INSIGHT-ESPRIT Study Group, SILCAAT Scientific Committee Interleukin-2 therapy in patients with HIV infection. N. Engl. J. Med. 2009, 361:1548-1559. 10.1056/NEJMoa0903175.
2. Agnellini P., Wolint P., Rehr M., Cahenzli J., Karrer U., Oxenius A. Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection. Proc. Natl. Acad. Sci. 2007, 104:4565-4570. 10.1073/pnas.0610335104.
3. Ahmadzadeh M., Johnson L.A., Heemskerk B., Wunderlich J.R., Dudley M.E., White D.E., Rosenberg S.A. Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 2009, 114:1537-1544. 10.1182/blood-2008-12-195792.
4. Alatrakchi N., Graham C.S., Vliet H.J.J.van der, Sherman K.E., Exley M.A., Koziel M.J. Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor β that can suppress HCV-specific T-cell responses. J. Virol. 2007, 81:5882-5892. 10.1128/JVI.02202-06.
5. Aldy K.N., Horton N.C., Mathew P.A., Mathew S.O. 2B4+ CD8+ T cells play an inhibitory role against constrained HIV epitopes. Biochem. Biophys. Res. Commun. 2011, 405:503-507. 10.1016/j.bbrc.2011.01.062.
6. Angelosanto J.M., Blackburn S.D., Crawford A., Wherry E.J. Progressive loss of memory T cell potential and commitment to exhaustion during chronic viral infection. J. Virol. 2012, 86:8161-8170. 10.1128/JVI.00889-12.
7. Appay V., Dunbar P.R., Callan M., Klenerman P., Gillespie G.M.A., Papagno L., Ogg G.S., King A., Lechner F., Spina C.A., Little S., Havlir D.V., Richman D.D., Gruener N., Pape G., Waters A., Easterbrook P., Salio M., Cerundolo V., McMichael A.J., Rowland-Jones S.L. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002, 8:379-385. 10.1038/nm0402-379.
8. Appay V., van Lier R.A.W., Sallusto F., Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 2008, 73A:975-983. 10.1002/cyto.a.20643.
9. Attridge K., Wang C.J., Wardzinski L., Kenefeck R., Chamberlain J.L., Manzotti C., Kopf M., Walker L.S.K. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. Blood 2012, 119:4656-4664. 10.1182/blood-2011-10-388546.
10. Bachmann M.F., Wolint P., Walton S., Schwarz K., Oxenius A. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections. Eur. J. Immunol. 2007, 37:1502-1512. 10.1002/eji.200637023.
11. Banerjee A., Gordon S.M., Intlekofer A.M., Paley M.A., Mooney E.C., Lindsten T., Wherry E.J., Reiner S.L. Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J. Immunol. 2010, 185:4988-4992. 10.4049/jimmunol.1002042.
12. Barber D.L., Wherry E.J., Masopust D., Zhu B., Allison J.P., Sharpe A.H., Freeman G.J., Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006, 439:682-687. 10.1038/nature04444.
13. Barker B.R., Gladstone M.N., Gillard G.O., Panas M.W., Letvin N.L. Critical role for IL-21 in both primary and memory anti-viral CD8+ T-cell responses. Eur. J. Immunol. 2010, 40:3085-3096. 10.1002/eji.200939939.
14. Battegay M., Moskophidis D., Rahemtulla A., Hengartner H., Mak T.W., Zinkernagel R.M. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice. J. Virol. 1994, 68:4700-4704.
15. Belz G.T., Xie W., Altman J.D., Doherty P.C. A previously unrecognized H-2Db-restricted peptide prominent in the primary influenza A virus-specific CD8+T-cell response is much less apparent following secondary challenge. J. Virol. 2000, 74:3486-3493. 10.1128/JVI.74.8.3486-3493.2000.
16. Bennett S.R.M., Carbone F.R., Karamalis F., Flavell R.A., Miller J.F.A.P., Heath W.R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 1998, 393:478-480. 10.1038/30996.
17. Betts M.R. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006, 107:4781-4789. 10.1182/blood-2005-12-4818.
18. Bhadra R., Gigley J.P., Weiss L.M., Khan I.A. Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade. Proc. Natl. Acad. Sci. 2011, 108:9196-9201. 10.1073/pnas.1015298108.
19. Blackburn S.D., Shin H., Freeman G.J., Wherry E.J. Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade. Proc. Natl. Acad. Sci. 2008, 105:15016-15021. 10.1073/pnas.0801497105.
20. Blackburn S.D., Shin H., Haining W.N., Zou T., Workman C.J., Polley A., Betts M.R., Freeman G.J., Vignali D.A.A., Wherry E.J. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 2008, 10:29-37. 10.1038/ni.1679.
21. Blattman J.N., Antia R., Sourdive D.J.D., Wang X., Kaech S.M., Murali-Krishna K., Altman J.D., Ahmed R. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 2002, 195:657-664. 10.1084/jem.20001021.
22. Blattman J.N., Grayson J.M., Wherry E.J., Kaech S.M., Smith K.A., Ahmed R. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 2003, 9:540-547. 10.1038/nm866.
23. Blattman J.N., Wherry E.J., Ha S.-J., Most R.G.van der, Ahmed R. Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infection. J. Virol. 2009, 83:4386-4394. 10.1128/JVI.02524-08.
24. Boni C., Fisicaro P., Valdatta C., Amadei B., Di Vincenzo P., Giuberti T., Laccabue D., Zerbini A., Cavalli A., Missale G., Bertoletti A., Ferrari C. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J. Virol. 2007, 81:4215-4225. 10.1128/JVI.02844-06.
25. Boyman O., Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 2012, 12:180-190. 10.1038/nri3156.
26. Brockman M.A., Kwon D.S., Tighe D.P., Pavlik D.F., Rosato P.C., Sela J., Porichis F., Le Gall S., Waring M.T., Moss K., Jessen H., Pereyra F., Kavanagh D.G., Walker B.D., Kaufmann D.E. IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 2009, 114:346-356. 10.1182/blood-2008-12-191296.
27. Brooks D.G., Lee A.M., Elsaesser H., McGavern D.B., Oldstone M.B.A. IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J. Exp. Med. 2008, 205:533-541. 10.1084/jem.20071948.
28. Brooks D.G., McGavern D.B., Oldstone M.B.A. Reprogramming of antiviral T cells prevents inactivation and restores T cell activity during persistent viral infection. J. Clin. Invest. 2006, 116:1675-1685. 10.1172/JCI26856.
29. Brooks D.G., Teyton L., Oldstone M.B.A., McGavern D.B. Intrinsic functional dysregulation of CD4 T cells occurs rapidly following persistent viral infection. J. Virol. 2005, 79:10514-10527. 10.1128/JVI.79.16.10514-10527.2005.
30. Brooks D.G., Trifilo M.J., Edelmann K.H., Teyton L., McGavern D.B., Oldstone M.B.A. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 2006, 12:1301-1309. 10.1038/nm1492.
31. Bucks C.M., Norton J.A., Boesteanu A.C., Mueller Y.M., Katsikis P.D. Chronic antigen stimulation alone is sufficient to drive CD8+ T cell exhaustion. J. Immunol. 2009, 182:6697-6708. 10.4049/jimmunol.0800997.
32. Caggiari L., Zanussi S., Crepaldi C., Bortolin M.T., Caffau C., D[U+05F3]Andrea M., De Paoli P. Different rates of CD4+ and CD8+ T-cell proliferation in interleukin-2-treated human immunodeficiency virus-positive subjects. Cytometry 2001, 46:233-237. 10.1002/cyto.1132.
33. Cai G., Anumanthan A., Brown J.A., Greenfield E.A., Zhu B., Freeman G.J. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 2008, 9:176-185. 10.1038/ni1554.
34. Cai G., Freeman G.J. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation. Immunol. Rev. 2009, 229:244-258. 10.1111/j.1600-065X.2009.00783.x.
35. Cecchinato V., Tryniszewska E., Ma Z.M., Vaccari M., Boasso A., Tsai W.-P., Petrovas C., Fuchs D., Heraud J.-M., Venzon D., Shearer G.M., Koup R.A., Lowy I., Miller C.J., Franchini G. Immune activation driven by CTLA-4 blockade augments viral replication at mucosal sites in simian immunodeficiency virus infection. J. Immunol. 2008, 180:5439-5447. 10.4049/jimmunol.180.8.5439.
36. Charles E.D., Dustin L.B. Hepatitis C virus-induced cryoglobulinemia. Kidney Int. 2009, 76:818-824. 10.1038/ki.2009.247.
37. Chen L., Flies D.B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 2013, 13:227-242. 10.1038/nri3405.
38. Chevalier M.F., Jülg B., Pyo A., Flanders M., Ranasinghe S., Soghoian D.Z., Kwon D.S., Rychert J., Lian J., Muller M.I., Cutler S., McAndrew E., Jessen H., Pereyra F., Rosenberg E.S., Altfeld M., Walker B.D., Streeck H. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J. Virol. 2011, 85:733-741. 10.1128/JVI.02030-10.
39. Chlewicki L.K., Velikovsky C.A., Balakrishnan V., Mariuzza R.A., Kumar V. Molecular basis of the dual functions of 2B4 (CD244). J. Immunol. 2008, 180:8159-8167. 10.4049/jimmunol.180.12.8159.
40. Clerici M., Wynn T.A., Berzofsky J.A., Blatt S.P., Hendrix C.W., Sher A., Coffman R.L., Shearer G.M. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 1994, 93:768-775. 10.1172/JCI117031.
41. Cook K.D., Whitmire J.K. The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection. J. Immunol. 2013, 190:641-649. 10.4049/jimmunol.1202448.
42. Cox M.A., Harrington L.E., Zajac A.J. Cytokines and the inception of CD8 T cell responses. Trends Immunol. 2011, 32:180-186. 10.1016/j.it.2011.01.004.
43. Cox M.A., Kahan S.M., Zajac A.J. Anti-viral CD8 T cells and the cytokines that they love. Virology 2013, 435:157-169. 10.1016/j.virol.2012.09.012.
44. Crawford A., Angelosanto J.M., Kao C., Doering T.A., Odorizzi P.M., Barnett B.E., Wherry E.J. Molecular and transcriptional basis of CD4+ T cell dysfunction during chronic infection. Immunity 2014, 40:289-302. 10.1016/j.immuni.2014.01.005.
45. Crome S.Q., Lang P.A., Lang K.S., Ohashi P.S. Natural killer cells regulate diverse T cell responses. Trends Immunol. 2013, 34:342-349. 10.1016/j.it.2013.03.002.
46. Crompton J.G., Clever D., Vizcardo R., Rao M., Restifo N.P. Reprogramming antitumor immunity. Trends Immunol. 2014, 35:178-185. 10.1016/j.it.2014.02.003.
47. Crouse J., Bedenikovic G., Wiesel M., Ibberson M., Xenarios I., Von Laer D., Kalinke U., Vivier E., Jonjic S., Oxenius A. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity 2014, 40:961-973. 10.1016/j.immuni.2014.05.003.
48. Cui W., Liu Y., Weinstein J.S., Craft J., Kaech S.M. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 2011, 35:792-805. 10.1016/j.immuni.2011.09.017.
49. Day C.L., Abrahams D.A., Lerumo L., Rensburg E.J.van, Stone L., O[U+05F3]rie T., Pienaar B., Kock M.de, Kaplan G., Mahomed H., Dheda K., Hanekom W.A. Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load. J. Immunol. 2011, 187:2222-2232. 10.4049/jimmunol.1101122.
50. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., Mackey E.W., Miller J.D., Leslie A.J., DePierres C., Mncube Z., Duraiswamy J., Zhu B., Eichbaum Q., Altfeld M., Wherry E.J., Coovadia H.M., Goulder P.J.R., Klenerman P., Ahmed R., Freeman G.J., Walker B.D. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354. 10.1038/nature05115.
51. de Goër de Herve M.G., Jaafoura S., Vallée M., Taoufik Y. FoxP3(+) regulatory CD4 T cells control the generation of functional CD8 memory. Nat. Commun. 2012, 3:986. 10.1038/ncomms1992.
52. Dienz O., Eaton S.M., Bond J.P., Neveu W., Moquin D., Noubade R., Briso E.M., Charland C., Leonard W.J., Ciliberto G., Teuscher C., Haynes L., Rincon M. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J. Exp. Med. 2009, 206:69-78. 10.1084/jem.20081571.
53. Doedens A.L., Phan A.T., Stradner M.H., Fujimoto J.K., Nguyen J.V., Yang E., Johnson R.S., Goldrath A.W. Hypoxia-inducible factors enhance the effector responses of CD8+ T cells to persistent antigen. Nat. Immunol. 2013, 14:1173-1182. 10.1038/ni.2714.
54. Doering T.A., Crawford A., Angelosanto J.M., Paley M.A., Ziegler C.G., Wherry E.J. Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory. Immunity 2012, 37:1130-1144. 10.1016/j.immuni.2012.08.021.
55. D'Souza W.N., Lefrançois L. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol. 2003, 171:5727-5735.
56. D'Souza W.N., Schluns K.S., Masopust D., Lefrançois L. Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses. J. Immunol. 2002, 168:5566-5572.
57. Ejrnaes M., Filippi C.M., Martinic M.M., Ling E.M., Togher L.M., Crotty S., von Herrath M.G. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 2006, 203:2461-2472. 10.1084/jem.20061462.
58. El-Far M., Halwani R., Said E., Trautmann L., Doroudchi M., Janbazian L., Fonseca S., van Grevenynghe J., Yassine-Diab B., Sékaly R.-P., Haddad E.K. T-cell exhaustion in HIV infection. Curr. HIV/AIDS Rep. 2008, 5:13-19.
59. Elsaesser H., Sauer K., Brooks D.G. IL-21 is required to control chronic viral infection. Science 2009, 324:1569-1572. 10.1126/science.1174182.
60. Eto D., Lao C., DiToro D., Barnett B., Escobar T.C., Kageyama R., Yusuf I., Crotty S. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One 2011, 6:e17739. 10.1371/journal.pone.0017739.
61. Fahey L.M., Wilson E.B., Elsaesser H., Fistonich C.D., McGavern D.B., Brooks D.G. Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J. Exp. Med. 2011, 208:987-999. 10.1084/jem.20101773.
62. Fantini M.C., Rizzo A., Fina D., Caruso R., Becker C., Neurath M.F., MacDonald T.T., Pallone F., Monteleone G. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur. J. Immunol. 2007, 37:3155-3163. 10.1002/eji.200737766.
63. Feng G., Zhang J.-Y., Zeng Q.-L., Jin L., Fu J., Yang B., Sun Y., Jiang T., Xu X., Zhang Z., Yuan J., Wu L., Wang F.-S. HCV-specific interleukin-21+CD4+ T cells responses associated with viral control through the modulation of HCV-specific CD8+ T cells function in chronic hepatitis C patients. Mol. Cells 2013, 36:362-367. 10.1007/s10059-013-0181-z.
64. Ferris R.L., Lu B., Kane L.P. Too much of a good thing? Tim-3 and TCR signaling in T cell exhaustion. J. Immunol. 2014, 193:1525-1530. 10.4049/jimmunol.1400557.
65. Fife B.T., Pauken K.E., Eagar T.N., Obu T., Wu J., Tang Q., Azuma M., Krummel M.F., Bluestone J.A. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol. 2009, 10:1185-1192. 10.1038/ni.1790.
66. Fontana A., Frei K., Bodmer S., Hofer E., Schreier M.H., Palladino M.A., Zinkernagel R.M. Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice. J. Immunol. 1989, 143:3230-3234.
67. Frebel H., Oxenius A. The risks of targeting co-inhibitory pathways to modulate pathogen-directed T cell responses. Trends Immunol. 2013, 34:193-199. 10.1016/j.it.2012.12.002.
68. Fröhlich A., Kisielow J., Schmitz I., Freigang S., Shamshiev A.T., Weber J., Marsland B.J., Oxenius A., Kopf M. IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science 2009, 324:1576-1580. 10.1126/science.1172815.
69. Fujita T., Burwitz B.J., Chew G.M., Reed J.S., Pathak R., Seger E., Clayton K.L., Rini J.M., Ostrowski M.A., Ishii N., Kuroda M.J., Hansen S.G., Sacha J.B., Ndhlovu L.C. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T Cells during Simian immunodeficiency virus infection in Rhesus Macaques. J. Immunol. 2014, 1400961. 10.4049/jimmunol.1400961.
70. Fuller M.J., Callendret B., Zhu B., Freeman G.J., Hasselschwert D.L., Satterfield W., Sharpe A.H., Dustin L.B., Rice C.M., Grakoui A., Ahmed R., Walker C.M. Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1). Proc. Natl. Acad. Sci. 2013, 110:15001-15006. 10.1073/pnas.1312772110.
71. Fuller M.J., Hildeman D.A., Sabbaj S., Gaddis D.E., Tebo A.E., Shang L., Goepfert P.A., Zajac A.J. Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help. J. Immunol. 2005, 174:5926-5930.
72. Fuller M.J., Khanolkar A., Tebo A.E., Zajac A.J. Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J. Immunol. 2004, 172:4204-4214.
73. Gallimore A., Glithero A., Godkin A., Tissot A.C., Plückthun A., Elliott T., Hengartner H., Zinkernagel R. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble tetrameric major histocompatibility complex Class I-Peptide complexes. J. Exp. Med. 1998, 187:1383-1393. 10.1084/jem.187.9.1383.
74. Gardiner D., Lalezari J., Lawitz E., DiMicco M., Ghalib R., Reddy K.R., Chang K.-M., Sulkowski M., Marro S.O., Anderson J., He B., Kansra V., McPhee F., Wind-Rotolo M., Grasela D., Selby M., Korman A.J., Lowy I. A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to Programmed Death-1 (PD-1), in patients with chronic hepatitis C virus infection. PLoS ONE 2013, 8:e63818. 10.1371/journal.pone.0063818.
75. Garidou L., Heydari S., Gossa S., McGavern D.B. Therapeutic blockade of transforming growth factor beta fails to promote clearance of a persistent viral infection. J. Virol. 2012, 86:7060-7071. 10.1128/JVI.00164-12.
76. Gaucher D., Therrien R., Kettaf N., Angermann B.R., Boucher G., Filali-Mouhim A., Moser J.M., Mehta R.S., Drake D.R., Castro E., Akondy R., Rinfret A., Yassine-Diab B., Said E.A., Chouikh Y., Cameron M.J., Clum R., Kelvin D., Somogyi R., Greller L.D., Balderas R.S., Wilkinson P., Pantaleo G., Tartaglia J., Haddad E.K., Sékaly R.-P. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J. Exp. Med. 2008, 205:3119-3131. 10.1084/jem.20082292.
77. Goepfert P.A., Bansal A., Edwards B.H., Ritter G.D., Tellez I., McPherson S.A., Sabbaj S., Mulligan M.J. A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J. Virol. 2000, 74:10249-10255. 10.1128/JVI.74.21.10249-10255.2000.
78. Golden-Mason L., Palmer B., Klarquist J., Mengshol J.A., Castelblanco N., Rosen H.R. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J. Virol. 2007, 81:9249-9258. 10.1128/JVI.00409-07.
79. Graw F., Richter K., Oxenius A., Regoes R.R. Comparison of cytotoxic T lymphocyte efficacy in acute and persistent lymphocytic choriomeningitis virus infection. Proc. R. Soc. B Biol. Sci. 2011, 278:3395-3402. 10.1098/rspb.2011.0453.
80. Haas A., Zimmermann K., Oxenius A. Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection. J. Virol. 2011, 85:12102-12113. 10.1128/JVI.05607-11.
81. Haining W.N., Ebert B.L., Subrmanian A., Wherry E.J., Eichbaum Q., Evans J.W., Mak R., Rivoli S., Pretz J., Angelosanto J., Smutko J.S., Walker B.D., Kaech S.M., Ahmed R., Nadler L.M., Golub T.R. Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cells. J. Immunol. 2008, 181:1859-1868. 10.4049/jimmunol.181.3.1859.
82. Hand T., Kaech S. Intrinsic and extrinsic control of effector T cell survival and memory T cell development. Immunol. Res. 2009, 45:46-61. 10.1007/s12026-008-8027-z.
83. Hannier S., Tournier M., Bismuth G., Triebel F. CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling. J. Immunol. 1998, 161:4058-4065.
84. Harker J.A., Lewis G.M., Mack L., Zuniga E.I. Late Interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 2011, 334:825-829. 10.1126/science.1208421.
85. Harrington L.E., Most R., van der, Whitton J.L., Ahmed R. Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope. J. Virol. 2002, 76:3329-3337. 10.1128/JVI.76.7.3329-3337.2002.
86. Hinrichs C.S., Spolski R., Paulos C.M., Gattinoni L., Kerstann K.W., Palmer D.C., Klebanoff C.A., Rosenberg S.A., Leonard W.J., Restifo N.P. IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood 2008, 111:5326-5333. 10.1182/blood-2007-09-113050.
87. Hunziker L., Recher M., Macpherson A.J., Ciurea A., Freigang S., Hengartner H., Zinkernagel R.M. Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections. Nat. Immunol. 2003, 4:343-349. 10.1038/ni911.
88. Hyodo N., Nakamura I., Imawari M. Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin. Exp. Immunol. 2004, 135:462-466. 10.1111/j.1365-2249.2003.02376.x.
89. Iannello A., Boulassel M.-R., Samarani S., Debbeche O., Tremblay C., Toma E., Routy J.-P., Ahmad A. Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study. J. Immunol. 2010, 184:114-126. 10.4049/jimmunol.0901967.
90. Ingram J.T., Yi J.S., Zajac A.J. Exhausted CD8 T cells downregulate the IL-18 receptor and become unresponsive to inflammatory cytokines and bacterial co-infections. PLoS Pathog. 2011, 7:e1002273. 10.1371/journal.ppat.1002273.
91. Intlekofer A.M., Takemoto N., Wherry E.J., Longworth S.A., Northrup J.T., Palanivel V.R., Mullen A.C., Gasink C.R., Kaech S.M., Miller J.D., Gapin L., Ryan K., Russ A.P., Lindsten T., Orange J.S., Goldrath A.W., Ahmed R., Reiner S.L. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 2005, 6:1236-1244. 10.1038/ni1268.
92. Janssen E.M., Droin N.M., Lemmens E.E., Pinkoski M.J., Bensinger S.J., Ehst B.D., Griffith T.S., Green D.R., Schoenberger S.P. CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005, 434:88-93. 10.1038/nature03337.
93. Jeannet G., Boudousquié C., Gardiol N., Kang J., Huelsken J., Held W. Essential role of the Wnt pathway effector Tcf-1 for the establishment of functional CD8 T cell memory. Proc. Natl. Acad. Sci. 2010, 107:9777-9782. 10.1073/pnas.0914127107.
94. Jin H.-T., Anderson A.C., Tan W.G., West E.E., Ha S.-J., Araki K., Freeman G.J., Kuchroo V.K., Ahmed R. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. 2010, 107:14733-14738. 10.1073/pnas.1009731107.
95. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., Irwin C.E., Safrit J.T., Mittler J., Weinberger L., Kostrikis L.G., Zhang L., Perelson A.S., Ho D.D. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected Macaques. J. Exp. Med. 1999, 189:991-998. 10.1084/jem.189.6.991.
96. Jones R.B., Ndhlovu L.C., Barbour J.D., Sheth P.M., Jha A.R., Long B.R., Wong J.C., Satkunarajah M., Schweneker M., Chapman J.M., Gyenes G., Vali B., Hyrcza M.D., Yue F.Y., Kovacs C., Sassi A., Loutfy M., Halpenny R., Persad D., Spotts G., Hecht F.M., Chun T.-W., McCune J.M., Kaul R., Rini J.M., Nixon D.F., Ostrowski M.A. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 2008, 205:2763-2779. 10.1084/jem.20081398.
97. Kaech S.M., Cui W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 2012, 12:749-761. 10.1038/nri3307.
98. Kalia V., Sarkar S., Subramaniam S., Haining W.N., Smith K.A., Ahmed R. Prolonged interleukin-2Ralpha expression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 2010, 32:91-103. 10.1016/j.immuni.2009.11.010.
99. Kao C., Oestreich K.J., Paley M.A., Crawford A., Angelosanto J.M., Ali M.-A.A., Intlekofer A.M., Boss J.M., Reiner S.L., Weinmann A.S., Wherry E.J. Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat. Immunol. 2011, 12:663-671. 10.1038/ni.2046.
100. Kaplan D.E., Ikeda F., Li Y., Nakamoto N., Ganesan S., Valiga M.E., Nunes F.A., Reddy K.R., Chang K.-M. Peripheral virus-specific T-cell Interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis. J. Hepatol. 2008, 48:903-913. 10.1016/j.jhep.2008.01.030.
101. Kared H., Fabre T., Bédard N., Bruneau J., Shoukry N.H. Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute Hepatitis C. PLoS Pathog. 2013, 9. 10.1371/journal.ppat.1003422.
102. Karnowski A., Chevrier S., Belz G.T., Mount A., Emslie D., D[U+05F3]Costa K., Tarlinton D.M., Kallies A., Corcoran L.M. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J. Exp. Med. 2012, 209:2049-2064. 10.1084/jem.20111504.
103. Kastenmuller W., Gasteiger G., Subramanian N., Sparwasser T., Busch D.H., Belkaid Y., Drexler I., Germain R.N. Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J. Immunol. 2011, 187:3186-3197. 10.4049/jimmunol.1101649.
104. Kaufmann D.E., Kavanagh D.G., Pereyra F., Zaunders J.J., Mackey E.W., Miura T., Palmer S., Brockman M., Rathod A., Piechocka-Trocha A., Baker B., Zhu B., Le Gall S., Waring M.T., Ahern R., Moss K., Kelleher A.D., Coffin J.M., Freeman G.J., Rosenberg E.S., Walker B.D. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Nat. Immunol. 2007, 8:1246-1254. 10.1038/ni1515.
105. Kekow J., Wachsman W., McCutchan J.A., Cronin M., Carson D.A., Lotz M. Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc. Natl. Acad. Sci. 1990, 87:8321-8325. 10.1073/pnas.87.21.8321.
106. Klenerman P., Hill A. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 2005, 6:873-879. 10.1038/ni1241.
107. Korn T., Bettelli E., Gao W., Awasthi A., Jäger A., Strom T.B., Oukka M., Kuchroo V.K. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 2007, 448:484-487. 10.1038/nature05970.
108. Kurachi M., Kurachi J., Suenaga F., Tsukui T., Abe Jun, Ueha S., Tomura M., Sugihara K., Takamura S., Kakimi K., Matsushima K. Chemokine receptor CXCR3 facilitates CD8+ T cell differentiation into short-lived effector cells leading to memory degeneration. J. Exp. Med. 2011, 208:1605-1620. 10.1084/jem.20102101.
109. Lang K.S., Recher M., Navarini A.A., Harris N.L., Löhning M., Junt T., Probst H.C., Hengartner H., Zinkernagel R.M. Inverse correlation between IL-7 receptor expression and CD8 T cell exhaustion during persistent antigen stimulation. Eur. J. Immunol. 2005, 35:738-745. 10.1002/eji.200425828.
110. Lang P.A., Lang K.S., Xu H.C., Grusdat M., Parish I.A., Recher M., Elford A.R., Dhanji S., Shaabani N., Tran C.W., Dissanayake D., Rahbar R., Ghazarian M., Brüstle A., Fine J., Chen P., Weaver C.T., Klose C., Diefenbach A., Häussinger D., Carlyle J.R., Kaech S.M., Mak T.W., Ohashi P.S. Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc. Natl. Acad. Sci. 2012, 109:1210-1215. 10.1073/pnas.1118834109.
111. Lechner F., Wong D.K.H., Dunbar P.R., Chapman R., Chung R.T., Dohrenwend P., Robbins G., Phillips R., Klenerman P., Walker B.D. Analysis of successful immune responses in persons infected with Hepatitis C virus. J. Exp. Med. 2000, 191:1499-1512. 10.1084/jem.191.9.1499.
112. Lee J., Su E.W., Zhu C., Hainline S., Phuah J., Moroco J.A., Smithgall T.E., Kuchroo V.K., Kane L.P. Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol. Cell. Biol. 2011, 31:3963-3974. 10.1128/MCB.05297-11.
113. Leonard W.J., Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat. Rev. Immunol. 2005, 5:688-698. 10.1038/nri1688.
114. Levy Y., Lacabaratz C., Weiss L., Viard J.-P., Goujard C., Lelièvre J.-D., Boué F., Molina J.-M., Rouzioux C., Avettand-Fénoêl V., Croughs T., Beq S., Thiébaut R., Chêne G., Morre M., Delfraissy J.-F. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J. Clin. Invest. 2009, 119:997-1007. 10.1172/JCI38052.
115. Li M.O., Wan Y.Y., Sanjabi S., Robertson A.-K.L., Flavell R.A. Transforming growth factor-β regulation of immune responses. Annu. Rev. Immunol. 2006, 24:99-146. 10.1146/annurev.immunol.24.021605.090737.
116. Li S., Vriend L.E.M., Nasser I.A., Popov Y., Afdhal N.H., Koziel M.J., Schuppan D., Exley M.A., Alatrakchi N. Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis. Hepatology 2012, 56:2094-2105. 10.1002/hep.25951.
117. Li Y., Ma S., Tang L., Li Y., Wang W., Huang X., Lai Q., Zhang M., Sun J., Li C.K., Abbott W.G.H., Naoumov N.V., Zhang Y., Hou J. Circulating chemokine (C-X-C Motif) receptor 5+CD4+ T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection. Hepatology 2013, 58:1277-1286. 10.1002/hep.26489.
118. Lu P., Youngblood B.A., Austin J.W., Mohammed A.U.R., Butler R., Ahmed R., Boss J.M. Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection. J. Exp. Med. 2014, 211:515-527. 10.1084/jem.20130208.
119. Mackerness K.J., Cox M.A., Lilly L.M., Weaver C.T., Harrington L.E., Zajac A.J. Pronounced virus-dependent activation drives exhaustion but sustains IFN-γ transcript levels. J. Immunol. 2010, 185:3643-3651. 10.4049/jimmunol.1000841.
120. Marchetti G., Meroni L., Molteni C., Bandera A., Franzetti F., Galli M., Moroni M., Clerici M., Gori A. Interleukin-2 immunotherapy exerts a differential effect on CD4 and CD8 T cell dynamics. AIDS 2004, 18:211-216.
121. Maris C.H., Chappell C.P., Jacob J. Interleukin-10 plays an early role in generating virus-specific T cell anergy. BMC Immunol. 2007, 8:8. 10.1186/1471-2172-8-8.
122. Matloubian M., Concepcion R.J., Ahmed R. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J. Virol. 1994, 68:8056-8063.
123. McMahan R.H., Golden-Mason L., Nishimura M.I., McMahon B.J., Kemper M., Allen T.M., Gretch D.R., Rosen H.R. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J. Clin. Invest. 2010, 120:4546-4557. 10.1172/JCI43127.
124. McMahon C.W., Zajac A.J., Jamieson A.M., Corral L., Hammer G.E., Ahmed R., Raulet D.H. Viral and bacterial infections induce expression of multiple NK cell receptors in responding CD8+ T cells. J. Immunol. 2002, 169:1444-1452. 10.4049/jimmunol.169.3.1444.
125. McNally A., Hill G.R., Sparwasser T., Thomas R., Steptoe R.J. CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis. Proc. Natl. Acad. Sci. 2011, 108:7529-7534. 10.1073/pnas.1103782108.
126. Miller J.D., van der Most R.G., Akondy R.S., Glidewell J.T., Albott S., Masopust D., Murali-Krishna K., Mahar P.L., Edupuganti S., Lalor S., Germon S., Del Rio C., Mulligan M.J., Staprans S.I., Altman J.D., Feinberg M.B., Ahmed R. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 2008, 28:710-722. 10.1016/j.immuni.2008.02.020.
127. Molloy M.J., Zhang W., Usherwood E.J. Suppressive CD8+ T cells arise in the absence of CD4 help and compromise control of persistent virus. J. Immunol. 2011, 186:6218-6226. 10.4049/jimmunol.1003812.
128. Moore K.W., Vieira P., Fiorentino D.F., Trounstine M.L., Khan T.A., Mosmann T.R. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 1990, 248:1230-1234. 10.1126/science.2161559.
129. Moskophidis D., Lechner F., Pircher H., Zinkernagel R.M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993, 362:758-761. 10.1038/362758a0.
130. Mueller S.N., Ahmed R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. 2009, 106:8623-8628. 10.1073/pnas.0809818106.
131. Mueller S.N., Gebhardt T., Carbone F.R., Heath W.R. Memory T cell subsets, migration patterns, and tissue residence. Annu. Rev. Immunol. 2013, 31:137-161. 10.1146/annurev-immunol-032712-095954.
132. Murali-Krishna K., Altman J.D., Suresh M., Sourdive D.J.., Zajac A.J., Miller J.D., Slansky J., Ahmed R. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 1998, 8:177-187. 10.1016/S1074-7613(00)80470-7.
133. Nachtwey J., Spencer J.V. HCMV IL-10 Suppresses Cytokine Expression in monocytes through inhibition of nuclear factor- κ B. Viral Immunol. 2008, 21:477-482. 10.1089/vim.2008.0048.
134. Nakamoto N., Kaplan D.E., Coleclough J., Li Y., Valiga M.E., Kaminski M., Shaked A., Olthoff K., Gostick E., Price D.A., Freeman G.J., Wherry E.J., Chang K. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 2008, 134:1927-1937. (e2). 10.1053/j.gastro.2008.02.033.
135. Nanjappa S.G., Kim E.H., Suresh M. Immunotherapeutic effects of IL-7 during a chronic viral infection in mice. Blood 2011, 117:5123-5132. 10.1182/blood-2010-12-323154.
136. Nikolova M., Marie-Cardine A., Boumsell L., Bensussan A. BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression. Int. Immunol. 2002, 14:445-451. 10.1093/intimm/14.5.445.
137. Nishimura T., Kaneko S., Kawana-Tachikawa A., Tajima Y., Goto H., Zhu D., Nakayama-Hosoya K., Iriguchi S., Uemura Y., Shimizu T., Takayama N., Yamada D., Nishimura K., Ohtaka M., Watanabe N., Takahashi S., Iwamoto A., Koseki H., Nakanishi M., Eto K., Nakauchi H. Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 2013, 12:114-126. 10.1016/j.stem.2012.11.002.
138. Odorizzi P.M., Wherry E.J. Inhibitory receptors on lymphocytes: insights from infections. J. Immunol. 2012, 188:2957-2965. 10.4049/jimmunol.1100038.
139. Oestreich K.J., Yoon H., Ahmed R., Boss J.M. NFATc1 regulates PD-1 expression upon T cell activation. J. Immunol. 2008, 181:4832-4839. 10.4049/jimmunol.181.7.4832.
140. Ohga S., Nomura A., Takada H., Tanaka T., Furuno K., Takahata Y., Kinukawa N., Fukushima N., Imai S., Hara T. Dominant expression of interleukin-10 and transforming growth factor-β genes in activated T-cells of chronic active epstein-barr virus infection. J. Med. Virol. 2004, 74:449-458. 10.1002/jmv.20197.
141. Osokine I., Snell L.M., Cunningham C.R., Yamada D.H., Wilson E.B., Elsaesser H.J., Torre J.C.de la, Brooks D. Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection. Proc. Natl. Acad. Sci. 2014, 111:7409-7414. 10.1073/pnas.1401662111.
142. Ou R., Zhou S., Huang L., Moskophidis D. Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J. Virol. 2001, 75:8407-8423. 10.1128/JVI.75.18.8407-8423.2001.
143. Oxenius A., Sewell A.K., Dawson S.J., Günthard H.F., Fischer M., Gillespie G.M., Rowland-Jones S.L., Fagard C., Hirschel B., Phillips R.E., Price D.A. Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load. J. Clin. Immunol. 2002, 22:363-374. 10.1023/A:1020656300027.
144. Oxenius A., Zinkernagel R.M., Hengartner H. Comparison of activation versus induction of unresponsiveness of virus-specific CD4+ and CD8+ T cells upon acute versus persistent viral infection. Immunity 1998, 9:449-457. 10.1016/S1074-7613(00)80628-7.
145. Paley M.A., Kroy D.C., Odorizzi P.M., Johnnidis J.B., Dolfi D.V., Barnett B.E., Bikoff E.K., Robertson E.J., Lauer G.M., Reiner S.L., Wherry E.J. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 2012, 338:1220-1225. 10.1126/science.1229620.
146. Pallikkuth S., Rogers K., Villinger F., DosterII M., Vaccari M., Franchini G., Pahwa R., Pahwa S. Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication. Vaccine 2011, 29:9229-9238. 10.1016/j.vaccine.2011.09.118.
147. Parish I.A., Marshall H.D., Staron M.M., Lang P.A., Brüstle A., Chen J.H., Cui W., Tsui Y.-C., Perry C., Laidlaw B.J., Ohashi P.S., Weaver C.T., Kaech S.M. Chronic viral infection promotes sustained Th1-derived immunoregulatory IL-10 via BLIMP-1. J. Clin. Invest. 2014, 124:3455-3468. 10.1172/JCI66108.
148. Pellegrini M., Calzascia T., Toe J.G., Preston S.P., Lin A.E., Elford A.R., Shahinian A., Lang P.A., Lang K.S., Morre M., Assouline B., Lahl K., Sparwasser T., Tedder T.F., Paik J., DePinho R.A., Basta S., Ohashi P.S., Mak T.W. IL-7 Engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 2011, 144:601-613. 10.1016/j.cell.2011.01.011.
149. Penaloza-MacMaster P., Kamphorst A.O., Wieland A., Araki K., Iyer S.S., West E.E., O[U+05F3]Mara L., Yang S., Konieczny B.T., Sharpe A.H., Freeman G.J., Rudensky A.Y., Ahmed R. Interplay between regulatory T cells and PD-1 in modulating T cell exhaustion and viral control during chronic LCMV infection. J. Exp. Med.. 2014, 211:1905-1918. (jem.20132577). 10.1084/jem.20132577.
150. Peng G., Li S., Wu W., Tan X., Chen Y., Chen Z. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol. Immunol. 2008, 45:963-970. 10.1016/j.molimm.2007.07.038.
151. Peretz Y., He Z., Shi Y., Yassine-Diab B., Goulet J.-P., Bordi R., Filali-Mouhim A., Loubert J.-B., El-Far M., Dupuy F.P., Boulassel M.R., Tremblay C., Routy J.-P., Bernard N., Balderas R., Haddad E.K., Sékaly R.-P. CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction. PLoS Pathog. 2012, 8:e1002840. 10.1371/journal.ppat.1002840.
152. Peritt D., Sesok-Pizzini D.A., Schretzenmair R., Macgregor R.R., Valiante N.M., Tu X., Trinchieri G., Kamoun M. C1.7 antigen expression on CD8+ T cells is activation dependent: increased proportion of C1.7+CD8+ T cells in HIV-1-infected patients with progressing disease. J. Immunol. 1999, 162:7563-7568.
153. Petrovas C., Casazza J.P., Brenchley J.M., Price D.A., Gostick E., Adams W.C., Precopio M.L., Schacker T., Roederer M., Douek D.C., Koup R.A. PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J. Exp. Med. 2006, 203:2281-2292. 10.1084/jem.20061496.
154. Petrovas C., Price D.A., Mattapallil J., Ambrozak D.R., Geldmacher C., Cecchinato V., Vaccari M., Tryniszewska E., Gostick E., Roederer M., Douek D.C., Morgan S.H., Davis S.J., Franchini G., Koup R.A. SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection. Blood 2007, 110:928-936. 10.1182/blood-2007-01-069112.
155. Pipkin M.E., Sacks J.A., Cruz-Guilloty F., Lichtenheld M.G., Bevan M.J., Rao A. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 2010, 32:79-90. 10.1016/j.immuni.2009.11.012.
156. Qiu Y., Chen J., Liao H., Zhang Y., Wang H., Li S., Luo Y., Fang D., Li G., Zhou B., Shen L., Chen C.Y., Huang D., Cai J., Cao K., Jiang L., Zeng G., Chen Z.W. Tim-3-expressing CD4+ and CD8+ T cells in human tuberculosis (TB) exhibit polarized effector memory phenotypes and stronger anti-TB effector functions. PLoS Pathog. 2012, 8:e1002984. 10.1371/journal.ppat.1002984.
157. Quigley M., Pereyra F., Nilsson B., Porichis F., Fonseca C., Eichbaum Q., Julg B., Jesneck J.L., Brosnahan K., Imam S., Russell K., Toth I., Piechocka-Trocha A., Dolfi D., Angelosanto J., Crawford A., Shin H., Kwon D.S., Zupkosky J., Francisco L., Freeman G.J., Wherry E.J., Kaufmann D.E., Walker B.D., Ebert B., Haining W.N. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat. Med. 2010, 16:1147-1151. 10.1038/nm.2232.
158. Radziewicz H., Ibegbu C.C., Fernandez M.L., Workowski K.A., Obideen K., Wehbi M., Hanson H.L., Steinberg J.P., Masopust D., Wherry E.J., Altman J.D., Rouse B.T., Freeman G.J., Ahmed R., Grakoui A. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J. Virol. 2007, 81:2545-2553. 10.1128/JVI.02021-06.
159. Raué H.-P., Beadling C., Haun J., Slifka M.K. Cytokine-mediated programmed proliferation of virus-specific CD8+ memory T cells. Immunity 2013, 38:131-139. 10.1016/j.immuni.2012.09.019.
160. Raué H.-P., Brien J.D., Hammarlund E., Slifka M.K. Activation of virus-specific CD8+ T cells by lipopolysaccharide-induced IL-12 and IL-18. J. Immunol. 2004, 173:6873-6881.
161. Raziorrouh B., Schraut W., Gerlach T., Nowack D., Grüner N.H., Ulsenheimer A., Zachoval R., Wächtler M., Spannagl M., Haas J., Diepolder H.M., Jung M.-C. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function. Hepatology 2010, 52:1934-1947. 10.1002/hep.23936.
162. Rehr M., Cahenzli J., Haas A., Price D.A., Gostick E., Huber M., Karrer U., Oxenius A. Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy. J. Virol. 2008, 82:3391-3404. 10.1128/JVI.02383-07.
163. Reignat S., Webster G.J.M., Brown D., Ogg G.S., King A., Seneviratne S.L., Dusheiko G., Williams R., Maini M.K., Bertoletti A. Escaping high viral load exhaustion CD8 cells with altered tetramer binding in chronic Hepatitis B virus infection. J. Exp. Med. 2002, 195:1089-1101. 10.1084/jem.20011723.
164. Richter K., Agnellini P., Oxenius A. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection. Int. Immunol. 2010, 22:13-23. 10.1093/intimm/dxp107.
165. Richter K., Brocker T., Oxenius A. Antigen amount dictates CD8+T-cell exhaustion during chronic viral infection irrespective of the type of antigen presenting cell. Eur. J. Immunol. 2012, 42:2290-2304. 10.1002/eji.201142275.
166. Richter K., Perriard G., Behrendt R., Schwendener R.A., Sexl V., Dunn R., Kamanaka M., Flavell R.A., Roers A., Oxenius A. Macrophage and T cell produced IL-10 promotes viral chronicity. PLoS Pathog. 2013, 9:e1003735. 10.1371/journal.ppat.1003735.
167. Richter K., Perriard G., Oxenius A. Reversal of chronic to resolved infection by IL-10 blockade is LCMV strain dependent. Eur. J. Immunol. 2013, 43:649-654. 10.1002/eji.201242887.
168. Ridge J.P., Di Rosa F., Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998, 393:474-478. 10.1038/30989.
169. Rottenberg M.E., Carow B. SOCS3, a major regulator of infection and inflammation. Mol. Innate Immun. 2014, 5:58. 10.3389/fimmu.2014.00058.
170. Rutebemberwa A., Ray S.C., Astemborski J., Levine J., Liu L., Dowd K.A., Clute S., Wang C., Korman A., Sette A., Sidney J., Pardoll D.M., Cox A.L. High-programmed Death-1 levels on Hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J. Immunol. 2008, 181:8215-8225. 10.4049/jimmunol.181.12.8215.
171. Sandler N.G., Bosinger S.E., Estes J.D., Zhu R.T.R., Tharp G.K., Boritz E., Levin D., Wijeyesinghe S., Makamdop K.N., del Prete G.Q., Hill B.J., Timmer J.K., Reiss E., Yarden G., Darko S., Contijoch E., Todd J.P., Silvestri G., Nason M., Norgren R.B., Keele B.F., Rao S., Langer J.A., Lifson J.D., Schreiber G., Douek D.C. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 2014, 511:601-605. 10.1038/nature13554.
172. Saraiva M., O[U+05F3]Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181. 10.1038/nri2711.
173. Schlaphoff V., Lunemann S., Suneetha P.V., Jaroszewicz J., Grabowski J., Dietz J., Helfritz F., Bektas H., Sarrazin C., Manns M.P., Cornberg M., Wedemeyer H. Dual function of the NK cell receptor 2B4 (CD244) in the regulation of HCV-specific CD8+ T cells. PLoS Pathog. 2011, 7:e1002045. 10.1371/journal.ppat.1002045.
174. Schmitz I., Schneider C., Fröhlich A., Frebel H., Christ D., Leonard W.J., Sparwasser T., Oxenius A., Freigang S., Kopf M. IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection. PLoS Pathog. 2013, 9:e1003362. 10.1371/journal.ppat.1003362.
175. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., Racz P., Tenner-Racz K., Dalesandro M., Scallon B.J., Ghrayeb J., Forman M.A., Montefiori D.C., Rieber E.P., Letvin N.L., Reimann K.A. Control of viremia in Simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860. 10.1126/science.283.5403.857.
176. Schoenberger S.P., Toes R.E.M., van der Voort E.I.H., Offringa R., Melief C.J.M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998, 393:480-483. 10.1038/31002.
177. Sereti I., Dunham R.M., Spritzler J., Aga E., Proschan M.A., Medvik K., Battaglia C.A., Landay A.L., Pahwa S., Fischl M.A., Asmuth D.M., Tenorio A.R., Altman J.D., Fox L., Moir S., Malaspina A., Morre M., Buffet R., Silvestri G., Lederman M.M. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009, 113:6304-6314. 10.1182/blood-2008-10-186601.
178. Shankar P., Russo M., Harnisch B., Patterson M., Skolnik P., Lieberman J. Impaired function of circulating HIV-specific CD8+ T cells in chronic human immunodeficiency virus infection. Blood 2000, 96:3094-3101.
179. Shin H., Blackburn S.D., Blattman J.N., Wherry E.J. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J. Exp. Med. 2007, 204:941-949. 10.1084/jem.20061937.
180. Shin H., Blackburn S.D., Intlekofer A.M., Kao C., Angelosanto J.M., Reiner S.L., Wherry E.J. A role for the transcriptional repressor Blimp-1 in CD8+ T cell exhaustion during chronic viral infection. Immunity 2009, 31:309-320. 10.1016/j.immuni.2009.06.019.
181. Slobedman B., Barry P.A., Spencer J.V., Avdic S., Abendroth A. Virus-Encoded homologs of cellular interleukin-10 and their control of host Immune Function. J. Virol. 2009, 83:9618. 10.1128/JVI.01098-09.
182. Spaan M., Kreefft K., de Graav G.N., Brouwer W.P., de Knegt R.J., ten Kate F.J.W., Baan C.C., Vanwolleghem T., Janssen H.L.A., Boonstra A. CD4+CXCR5+ T-cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B-cell responses. J. Hepatol. 2014, 10.1016/j.jhep.2014.09.024.
183. Stelekati E., Shin H., Doering T.A., Dolfi D.V., Ziegler C.G., Beiting D.P., Dawson L., Liboon J., Wolski D., Ali M.-A.A., Katsikis P.D., Shen H., Roos D.S., Haining W.N., Lauer G.M., Wherry E.J. Bystander chronic infection negatively impacts development of CD8+ T cell memory. Immunity 2014, 40:801-813. 10.1016/j.immuni.2014.04.010.
184. Stinchcombe J.C., Bossi G., Booth S., Griffiths G.M. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 2001, 15:751-761. 10.1016/S1074-7613(01)00234-5.
185. Streeck H., Brumme Z.L., Anastario M., Cohen K.W., Jolin J.S., Meier A., Brumme C.J., Rosenberg E.S., Alter G., Allen T.M., Walker B.D., Altfeld M. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med. 2008, 5:e100. 10.1371/journal.pmed.0050100.
186. Teijaro J.R., Ng C., Lee A.M., Sullivan B.M., Sheehan K.C.F., Welch M., Schreiber R.D., Torre J.C., de la, Oldstone M.B.A. Persistent LCMV infection is controlled by blockade of Type I interferon signaling. Science 2013, 340:207-211. 10.1126/science.1235214.
187. Tinoco R., Alcalde V., Yang Y., Sauer K., Zuniga E.I. Cell-intrinsic transforming growth factor-β signaling mediates virus-specific CD8+ T cell deletion and viral persistence In Vivo. Immunity 2009, 31:145-157. 10.1016/j.immuni.2009.06.015.
188. Tinoco R., Alcalde V., Yang Y., Sauer K., Zuniga E.I. TGF-? signaling in T cells is essential for CD8 T cell suppression and viral persistence In Vivo. Immunity 2009, 31:145-157. 10.1016/j.immuni.2009.06.015.
189. Trautmann L., Janbazian L., Chomont N., Said E.A., Gimmig S., Bessette B., Boulassel M.-R., Delwart E., Sepulveda H., Balderas R.S., Routy J.-P., Haddad E.K., Sekaly R.-P. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 2006, 12:1198-1202. 10.1038/nm1482.
190. Tsujimura K., Obata Y., Matsudaira Y., Nishida K., Akatsuka Y., Ito Y., Demachi-Okamura A., Kuzushima K., Takahashi T. Characterization of murine CD160+ CD8+ T lymphocytes. Immunol. Lett. 2006, 106:48-56. 10.1016/j.imlet.2006.04.006.
191. Tussey L.G., Nair U.S., Bachinsky M., Edwards B.H., Bakari J., Grimm K., Joyce J., Vessey R., Steigbigel R., Robertson M.N., Shiver J.W., Goepfert P.A. Antigen burden is a major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization. J. Infect. Dis. 2003, 187:364-374. 10.1086/367707.
192. Utzschneider D.T., Legat A., Fuertes Marraco S.A., Carrié L., Luescher I., Speiser D.E., Zehn D. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. Nat. Immunol. 2013, 14:603-610. 10.1038/ni.2606.
193. Vahedi G., Takahashi H., Nakayamada S., Sun H., Sartorelli V., Kanno Y., O[U+05F3]Shea J.J. STATs shape the active enhancer landscape of T cell populations. Cell 2012, 151:981-993. 10.1016/j.cell.2012.09.044.
194. Velu V., Titanji K., Zhu B., Husain S., Pladevega A., Lai L., Vanderford T.H., Chennareddi L., Silvestri G., Freeman G.J., Ahmed R., Amara R.R. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 2009, 458:206-210. 10.1038/nature07662.
195. Vizcardo R., Masuda K., Yamada D., Ikawa T., Shimizu K., Fujii S., Koseki H., Kawamoto H. Regeneration of human tumor antigen-specific T cells from iPSCs derived from mature CD8+ T cells. Cell Stem Cell 2013, 12:31-36. 10.1016/j.stem.2012.12.006.
196. Waggoner S.N., Cornberg M., Selin L.K., Welsh R.M. Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012, 481:394-398. 10.1038/nature10624.
197. Waggoner S.N., Daniels K.A., Welsh R.M. Therapeutic depletion of natural killer cells controls persistent infection. J. Virol. 2014, 88:1953-1960. 10.1128/JVI.03002-13.
198. Wei F., Zhong S., Ma Z., Kong H., Medvec A., Ahmed R., Freeman G.J., Krogsgaard M., Riley J.L. Strength of PD-1 signaling differentially affects T-cell effector functions. Proc. Natl. Acad. Sci. 2013, 110:E2480-E2489. 10.1073/pnas.1305394110.
199. Welsh R.M., Waggoner S.N. NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections. Virology 2013, 435:37-45. 10.1016/j.virol.2012.10.005.
200. West E.E., Jin H.-T., Rasheed A.-U., Penaloza-MacMaster P., Ha S.-J., Tan W.G., Youngblood B., Freeman G.J., Smith K.A., Ahmed R. PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells. J. Clin. Invest. 2013, 123:2604-2615. 10.1172/JCI67008.
201. Wherry E.J. T cell exhaustion. Nat. Immunol. 2011, 12:492-499.
202. Wherry E.J., Barber D.L., Kaech S.M., Blattman J.N., Ahmed R. Antigen-independent memory CD8 T cells do not develop during chronic viral infection. Proc. Natl. Acad. Sci. USA 2004, 101:16004-16009. 10.1073/pnas.0407192101.
203. Wherry E.J., Blattman J.N., Murali-Krishna K., Most R.van der, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 2003, 77:4911-4927. 10.1128/JVI.77.8.4911-4927.2003.
204. Wherry E.J., Ha S.-J., Kaech S.M., Haining W.N., Sarkar S., Kalia V., Subramaniam S., Blattman J.N., Barber D.L., Ahmed R. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 2007, 27:670-684. 10.1016/j.immuni.2007.09.006.
205. Wiesel M., Joller N., Ehlert A.-K., Crouse J., Spörri R., Bachmann M.F., Oxenius A. Th cells act via two synergistic pathways to promote antiviral CD8+ T cell responses. J. Immunol. 2010, 185:5188-5197. 10.4049/jimmunol.1001990.
206. Wiesel M., Kratky W., Oxenius A. Type I IFN substitutes for T cell help during viral infections. J. Immunol. 2011, 186:754-763. 10.4049/jimmunol.1003166.
207. + T-cell help. Eur. J. Immunol. 2012, 42:1080-1088. 10.1002/eji.201142205.
208. Williams L.D., Bansal A., Sabbaj S., Heath S.L., Song W., Tang J., Zajac A.J., Goepfert P.A. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J. Virol. 2011, 85:2316-2324. 10.1128/JVI.01476-10.
209. Williams M.A., Tyznik A.J., Bevan M.J. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature 2006, 441:890-893. 10.1038/nature04790.
210. Wilson E.B., Kidani Y., Elsaesser H., Barnard J., Raff L., Karp C.L., Bensinger S., Brooks D.G. Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection. Cell Host Microbe 2012, 11:481-491. 10.1016/j.chom.2012.03.009.
211. Wilson E.B., Yamada D.H., Elsaesser H., Herskovitz J., Deng J., Cheng G., Aronow B.J., Karp C.L., Brooks D.G. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 2013, 340:202-207. 10.1126/science.1235208.
212. Xu H.C., Grusdat M., Pandyra A.A., Polz R., Huang J., Sharma P., Deenen R., Köhrer K., Rahbar R., Diefenbach A., Gibbert K., Löhning M., Höcker L., Waibler Z., Häussinger D., Mak T.W., Ohashi P.S., Lang K.S., Lang P.A. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity. Immunity 2014, 40:949-960. 10.1016/j.immuni.2014.05.004.
213. Yi J.S., Cox M.A., Zajac A.J. T-cell exhaustion: characteristics, causes and conversion. Immunology 2010, 129:474-481. 10.1111/j.1365-2567.2010.03255.x.
214. Yi J.S., Cox M.A., Zajac A.J. Interleukin-21: a multifunctional regulator of immunity to infections. Microbes Infect. Inst. Pasteur 2010, 12:1111-1119. 10.1016/j.micinf.2010.08.008.
215. Yi J.S., Du M., Zajac A.J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009, 324:1572-1576. 10.1126/science.1175194.
216. Youngblood B., Noto A., Porichis F., Akondy R.S., Ndhlovu Z.M., Austin J.W., Bordi R., Procopio F.A., Miura T., Allen T.M., Sidney J., Sette A., Walker B.D., Ahmed R., Boss J.M., Sékaly R.-P., Kaufmann D.E. Cutting edge: prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cells. J. Immunol. Baltim. MD 2013, 1950(191):540-544. 10.4049/jimmunol.1203161.
217. Youngblood B., Oestreich K.J., Ha S.-J., Duraiswamy J., Akondy R.S., West E.E., Wei Z., Lu P., Austin J.W., Riley J.L., Boss J.M., Ahmed R. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8+ T cells. Immunity 2011, 35:400-412. 10.1016/j.immuni.2011.06.015.
218. Yue F.Y., Lo C., Sakhdari A., Lee E.Y., Kovacs C.M., Benko E., Liu J., Song H., Jones R.B., Sheth P., Chege D., Kaul R., Ostrowski M.A. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control. J. Immunol. 2010, 185:498-506. 10.4049/jimmunol.0903915.
219. Zajac A.J., Blattman J.N., Murali-Krishna K., Sourdive D.J.D., Suresh M., Altman J.D., Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J. Exp. Med. 1998, 188:2205-2213. 10.1084/jem.188.12.2205.
220. Zhang F., Zhou X., DiSpirito J.R., Wang C., Wang Y., Shen H. Epigenetic manipulation restores functions of defective CD8+ T cells from chronic viral infection. Mol. Ther. 2014, 10.1038/mt.2014.91.
221. Zhou S., Ou R., Huang L., Price G.E., Moskophidis D. Differential tissue-specific regulation of antiviral CD8+ T-cell immune responses during chronic viral infection. J. Virol. 2004, 78:3578-3600. 10.1128/JVI.78.7.3578-3600.2004.
222. Zhou X., Xue H.-H. Cutting edge: generation of memory precursors and functional memory CD8+ T cells depends on T cell factor-1 and lymphoid enhancer-binding factor-1. J. Immunol. 2012, 189:2722-2726. 10.4049/jimmunol.1201150.
223. Zhou X., Yu S., Zhao D.-M., Harty J.T., Badovinac V.P., Xue H.-H. Differentiation and persistence of memory CD8+ T cells depend on T cell factor 1. Immunity 2010, 33:229-240. 10.1016/j.immuni.2010.08.002.